Maxim Shustov

Mr. Maxim Shustov


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SZSvetlana Sergeevna Zykova
Svetlana Sergeevna Zykova
TGTatyana Gessel
Tatyana Gessel
AGAigul Galembikova
Aigul Galembikova
EMEvgenii Mozhaitsev
Evgenii Mozhaitsev
Sophia S. BorisevichSophia S. Borisevich
Sophia S. Borisevich
Sergei BoichukSergei Boichuk
Sergei Boichuk
Background: Hypoxia-inducible factor-1α (HIF-1α) is a well-known transcriptional regulator that mediates a broad spectrum of cellular responses to hypoxia, including angiogenesis, extracellular matrix remodeling, and metabolic reprogramming. These activities can be achieved by upregulation of numerous genes, such as vascular endothelial growth factors, fibroblast growth factors, and platelet-derived growth factors, which are involved in the growth regulation of normal tissues and solid tumors. Notably, HIF-1α-mediated regulation of the solid tumor’s microenvironment effectively modulates tumor sensitivity to anticancer therapies and thereby can contribute to disease progression. Methods: The study was performed on breast, lung and prostate cancer cell lines. Protein expression was examined by western blotting. Antitumor activity of 2-ANPC was measured by syngeneic 4T1 breast cancer mouse model. Results: We show here that a 2-aminopyrrole derivative (2-amino-1-benzamido-5-(2-(naphthalene-2-yl)-2-oxoethylidene)-4-oxo-4,5-dihydro-1-H-pyrrole-3-carboxamide—2-ANPC), previously shown as a potent microtubule-targeting agent, effectively downregulates HIF-1α expression in a broad spectrum of cancer cell lines, including breast, lung, and prostate cancer. The downregulation of HIF-1α expression in 2-ANPC-treated cancer cells was due to enhanced proteasome-mediated degradation, whereas the proteasome inhibitor MG-132 effectively reversed this downregulation. 2-ANPC’s potency in downregulating HIF-1α was also shown in vivo by using the 4T1 breast cancer syngraft model. Importantly, this 2-aminopyrrole derivative also downregulated the expression of vascular endothelial growth factor receptors 1 and 3 (VEGFR1 and 3) in 4T1 tumors, which correlated with decreased tumor weight and size. As expected, an increase in apoptotic (i.e., cleaved caspase-3-positive) cells was detected in 4T1 tumors treated with 2-aminopyrrole derivative. Lastly, using various computational tools, we identified four potential binding sites for 2-ANPC to interact with HIF-1α, HIF-1β, and the p300 complex. Conclusions: Collectively, we show here, for the first time, that HIF-1α is a novel molecular target for the 2-aminopyrrole derivative (2-ANPC), thereby illustrating it as a potential scaffold for the development of potent chemotherapeutic agents with anti-angiogenic activity.

12 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SZSvetlana Sergeevna Zykova
Svetlana Sergeevna Zykova
TGTatyana Gessel
Tatyana Gessel
AGAigul Galembikova
Aigul Galembikova
EMEvgenii Mozhaitsev
Evgenii Mozhaitsev
Sophia S. BorisevichSophia S. Borisevich
Sophia S. Borisevich
Sergei BoichukSergei Boichuk
Sergei Boichuk
Hypoxia-inducible factor-1α (HIF-1α) is a well-known transcriptional regulator that me-diates a broad spectrum of cellular responses to hypoxia, including angiogenesis, extra-cellular matrix remodeling, and metabolic reprogramming. These activities can be achieved by up-regulation of numerous genes, such as vascular endothelial growth fac-tors, fibroblast growth factors, and platelet-derived growth factors, which are involved in the growth regulation of normal tissues and solid tumors. Of note, HIF-1α-mediated regu-lation of the solid tumor’s microenvironment effectively modulates tumor sensitivity to anticancer therapies and thereby can contribute to disease progression. We show here that a 2-aminopyrrole derivative (2-amino-1-benzamido-5-(2-(naphthalene-2-yl)-2-oxoethylidene)-4-oxo-4,5-dihydro-1-H-pyrrole-3-carboxamide – 2-ANPC), previously shown as a potent microtubule-targeting agent, effectively down-regulates HIF-1α expression in a broad spectrum of cancer cell lines, including breast, lung, and prostate cancer. The downregulation of HIF-1α expression in 2-ANPC-treated cancer cells was due to en-hanced proteasome-mediated degradation, whereas the proteasome inhibitor MG-132 ef-fectively reversed this downregulation. 2-ANPC’s potency to down-regulate HIF-1α was also shown in vivo by using the 4T1 breast cancer syngraft model. Important, this 2-aminopyrrole derivative also down-regulated the expression of vascular endothelial growth factor receptors 1 and 3 (VEGFR1 and 3) in 4T1 tumors, which correlated with de-creased tumor weight and size. As expected, an increase of apoptotic (i.e., cleaved caspa-se-3-positive) cells was detected in 4T1 tumors treated with 2-aminopyrrole derivative. Lastly, using various computational tools, we identified four potential binding sites for 2-ANPC to interact with HIF-1α, HIF-1β, and the p300 complex. Collectively, we show here, for the first time, that HIF-1α is a novel molecular target for the 2-aminopyrrole de-rivative (2-ANPC), thereby illustrating it as a potential scaffold for the development of po-tent chemotherapeutic agents with anti-angiogenic activity.

26 December 2023 in Drug development & registration
Verified
Journal Article
Open access
PDF file
SZSvetlana Sergeevna Zykova
Svetlana Sergeevna Zykova
MSMaxim Shustov
Maxim Shustov
VTV. S. Talismanov
V. S. Talismanov
Introduction. Modern chemotherapy widely considers the role of antioxidant and pro-oxidant methods in the treatment of oncologic pathologies. The use of agents that cause an increase of ROS is a relevant way to destroy tumors. At the same time, there is evidence of the ability of some antioxidants to lead to the cancer cells apoptosis through the generation of free radical forms of oxygen due to disruption of cellular homeostasis. The combination of the «Ecolum» biosensor using technique, antiradical activity data, and information about the cytotoxicity of compounds used in the study allows us to consistently conduct low-cost screening of as antioxidant, as antiradical activities and potentially reduce the required number of expensive cytotoxicity determinations using tumor cells.Aim. The main target of our work is the evaluation of antioxidant and cytotoxic activities of 1,3-dioxolane derivatives of imidazole using antioxidant, antiradical and cytotoxicity tests in vitro.Materials and methods. To carry out this study, 1,3-dioxolane derivatives of imidazole were obtained. The antiradical tests was performed using the DPPH (2,2-diphenyl-1-picrylhydrazyl) method. Antioxidant properties were assessed within the Ecolum biosensor in the state of oxidative stress. Cytotoxic activity was assessed in GIST-T1 cell culture using the MTT test (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide).Results and discussion. Data from studies of the antioxidant activity of substances using the «Ecolum» biosensor showed varying degrees of damage to the biosensor in the absence of antioxidant action. The antiradical potential, initially used to reveal a possible mechanism of antioxidant action, actually demonstrated a possible mechanism of toxic action of substance 2c due to its antiradical effect comparable to the standard (Trolox), but the substance has the highest cytotoxicity. However, the properties of substance 2a shows that the direct correlation discussed earlier is not found in all cases.Conclusion. The asessment of the antioxidant properties and cytotoxic activity of 1,3-dioxolane derivatives of imidazole demonstrated the relevance of further searching for connections between the results of substances binding with the Ecolum biosensor under conditions of oxidative stress, their antiradical potential and cytotoxic properties. This combination of tests will potentially reduce the cost of screening through the use of an available biosensor, establish a possible mechanism of action aimed at redox balance, and confirm previously obtained data through the use of tumor cell culture.

19 April 2025 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
MSMaxim Shustov
Maxim Shustov
SZSvetlana Sergeevna Zykova
Svetlana Sergeevna Zykova
PSPopkov S.V.
Popkov S.V.
TGTsaplin G.V.
Tsaplin G.V.
TVTalismanov V.S.
Talismanov V.S.
SRSlobodyanik R.V.
Slobodyanik R.V.
The search for new agents with anthelmintic and larvicidal types of action is so relevant due to the frequent appear of resistance of helminths and larvae to the main drugs used due to significant and, in some cases, uncontrollable use or the development of resistance to entire classes of drugs due to their common chemical structure. In this search for new agents, we are performed study of aza-heterocyclic compounds of various structures, obtained experimental data reflecting the expression of anthelmintic and larvicidal activities. The study of the effect of compounds on helminths was carried out using Dandrobaena veneta worms in comparison with the standard drug, levamisole. Larvicidal activity was assessed on chiromonid larvae (Diptera, Chironomidae) in comparison with the drug imidacloprid. The degree of acute toxicity of the compounds was established on white mice with per os administration. The results of the studies showed that 4 compounds have larvicidal activity as the level of the comparison drug, 3 compounds have anthelmintic action as the level of the standard used. The data were obtained reveals low toxicity of the all studied compounds. In general, the results are allowed us to state the high value of new potential agents, while some features of the final result are should be noted separately. The studied compounds do not have significant structural similarity with the most common anthelmintic and larvicidal drugs, which can potentially complicate the development of resistance of target species. It is also worth noting that individual leading substances are many times superior to comparison drugs in terms of the effective dose. Given these circumstances, the authors' team successfully patented one of the compounds in the field of application as an anthelmintic and larvicidal agent.

26 December 2022 in Drug development & registration
Verified
Journal Article
Open access
PDF file
SZSvetlana Sergeevna Zykova
Svetlana Sergeevna Zykova
КГК. Л. Ганькова
К. Л. Ганькова
MSMaxim Shustov
Maxim Shustov
NINazim M. Igidov
Nazim M. Igidov
Sophia S. BorisevichSophia S. Borisevich
Sophia S. Borisevich
Margarita G. IlyinaMargarita G. Ilyina
Margarita G. Ilyina
Introduction. Modern therapy defines oxidative stress as one of the key links in the pathogenesis of different diseases, which makes the search for new low molecular weight antioxidants actual [1]. The widely used methods are imperfect, since they reflects reactivity of the sample under artificial conditions [2–4]. The proposed technique of using the "Ecolum" biosensor makes it possible to preserve the advantages of in vitro methods and improve the accuracy of determination through the use of biological reactions of cells [5, 6].Aim. Studying of the antiradical and antioxidant activity of 2-aminopyrroles, using in vitro methods and quantum-chemical calculations. Materials and methods. Earlier, derivatives of 2-aminopyrroles were obtained. Antiradical activity of the compounds was studied using the DPPH test (2,2-diphenyl-1-picrylhydrazyl). Antioxidant activity was evaluated on the model of oxidative stress using the «Ecolum» biosensor. The calculation data of the indices of reactivity in the approximation of the gas phase were obtained using quantum-chemical methods.Results and discussion. The antioxidant activity test indicated a higher antioxidant potential of 2a, compared to 2b. Antiradical activity test revealed a greater antiradical potential of 2b. Quantum-chemical calculations showed that 2b is characterized by a higher ionization potential, which may indicate its greater resistance to oxidation compared to 2a.Conclusion. The study of the antiradical and antioxidant activity of 2-aminopyrroles showed the importance of developing a methodology for the search for new antioxidants, because of antiradical activity test deviations, compared to living cell reactions.